Original Research
Published on 24 Mar 2022
Re-Expression of ERα and AR in Receptor Negative Endocrine Cancers via GSK3 Inhibition
in Cancer Molecular Targets and Therapeutics
- 3,165 views
- 4 citations
Original Research
Published on 24 Mar 2022
in Cancer Molecular Targets and Therapeutics
Mini Review
Published on 24 Mar 2022
in Cancer Molecular Targets and Therapeutics
Review
Published on 23 Mar 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 22 Mar 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 22 Mar 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 22 Mar 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 17 Mar 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 17 Mar 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 17 Mar 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 16 Mar 2022
in Cancer Molecular Targets and Therapeutics
Review
Published on 16 Mar 2022
in Cancer Molecular Targets and Therapeutics
Review
Published on 16 Mar 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 16 Mar 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 14 Mar 2022
in Cancer Molecular Targets and Therapeutics
Editorial
Published on 14 Mar 2022
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 11 Mar 2022
in Cancer Molecular Targets and Therapeutics